GSK-3β inhibitor
KPUM-UH1, Karpas 422 and TMD8 cells were lysed and analyzed for total GSK-3β, p-GSK-3β (Y216) and stripped and re-probed for β-Actin (loading control) as described in materials and methods. The band intensities were calculated using Image J (NIH) software and normalized to β-actin control, and the relative values for all cell lines compared to Daudi is shown. Note that p-GSK-3β (Y216) has 2 bands, and the quantification is shown for both. However, the top band may represent the ɑ-isoform due to the possibility of antibody crossreactivity and has not been verified. 50,000 cells were plated in 96-well plate wells and treated with varying concentrations of 9-ING-41. Seventy two hours later, cell viability was determined using, MTS assay. Briefly, 20μl of MTS reagent was added to cells and incubated for 2 hours and, absorbance at 490 nm was read using a Biotek plate reader. Relative absorbance is calculated after setting the average absorbance of the no-treatment control as 1. (B) 100,000 cells were plated in 12-well plate wells in duplicate and treated with varying concentrations of 9-ING-41. Twenty four hours later, cells were lysed and analyzed for caspase 3/7 activity as described in materials and methods. The average of the duplicate is shown in the graph.
